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Background & Aims: Intraileal nutrients modulate gas­
trointestinal motility, but effects of maldigestion on 
postprandial motility are unknown. The aim of this 
study was to compare motor responses with ileal nutri­
ent exposure in health and pancreatic insufficiency 
i
after a meal or intraluminal perfusion. Methods: After 
oroileal multilumen intubation for duodeno-jejuno-lleal 
sampling, marker perfusion, and motility recording, 14 
normal subjects and 12 patients with severe pancre­
atic insufficiency received a labeled liquid meal twice, 
either with placebo or pancreatin. Effects of intraileal 
nutrient perfusion on fed motility induced by duodenal 
amino acid perfusion were also investigated. Results: 
Compared with normals, untreated patients had 
greater cumulative ileal nutrient delivery (69 ±  21 vs. 
487 ±  232 kJ), shorter fed pattern (196 ±  22 vs. 131  
±  14 minutes), greater 90% gastric emptying (163 ±
12 vs. 128 ±  10 minutes), and faster small intestinal 
transit (86 ±  9 vs. 44 ±  6 minutes). Pancreatin re­
versed these changes. Ileal nutrient perfusion con­
verted fed into interdigestive-like motility in normals (7 
of 8) and patients (4 of 5). Conclusions: In subjects 
with pancreatic insufficiency, a low-energy liquid meal 
induces shorter fed motor pattern associated with ac­
celerated gastric emptying and intestinal transit com­
pared with healthy subjects. Because changes re­
sponded to enzyme treatment and could be reproduced 
by ileal nutrient perfusion, ileal delivery of malabsorbed 
chyme may be involved as a mechanism.
U nder physiological conditions, gastrointestinal m o­tility  and exocrine pancreatic secretion are regu­
lated in concert ,1-3 but only a few studies have addressed 
the question o f  whether postprandial m otility  is altered 
when pancreatic function is disturbed. In chronic pancre­
atitis, contradictory results have been reported for gastric 
m otility , ~7 and intestinal m otility  has not been studied. 
However, because nutrient exposure o f  the small in testi­
nal lumen is a major regulatory factor controlling gastro­
intestinal m otor functions, it  is conceivable that post­
prandial m otility  is affected in  states of increased
quantities o f  unabsorbed nutrient delivered to proximal 
and distal small intestinal sites as expected in untreated 
severe exocrine pancreatic insufficiency.8 This concept 
is supported by several studies showing that increased 
nutrient loads delivered to the distal intestine modulate 
human intestinal motility.
Consequently, we reasoned that motor regulation in  
the late-postprandial period may be altered in severe 
exocrine pancreatic insufficiency. To test this hypothesis, 
we used two different experimental protocols.
In protocol 1, we compared postprandial motor re­
sponses after a standardized low-energy liquid test meal 
am ong normal subjects and patients with untreated pan­
creatic insufficiency and correlated them with nutrient 
delivery rates w ith in  the proximal and distal small intes­
tinal lumen. These experiments were repeated in the  
same subjects to determine the effects o f  pancreatic en­
zyme supplementation.
In protocol 2 , we compared the effects of intraileal 
perfusion o f  nutrient w ith  those of saline (as volume  
control) on fed m otility  both in normal individuals and 
patients w ith  chronic pancreatitis, using the same sub­
jects as their own controls. Duodenal and ileal nutrient 
loads were chosen to be o f similar magnitude as those 
measured in protocol 1 during the third postprandial 
hour in untreated pancreatic insufficiency.
Materials and Methods
Patients and Normal Subjects
The protocol was approved by the Institutional Ethical 
Committee. After giving informed written consent, 22 healthy 
subjects (15 men and 7 women; age range, 2 2 -4 6  years) and
12 patients with chronic pancreatic insufficiency (9 men and
3 women; age range, 3 4 -5 9  years) participated in the study. 
All healthy subjects had a normal history and no abnormalities 
on physical examination.
Abbreviations used in this paper: GLP-1, glucagon-like peptide 1; 
PSPr phenolsulfonphthalein.
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Table 1. Clinical Characteristics of the Patients With Chronic Pancreatitis and Severe Exocrine Pancreatic Insufficiency
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Duration of Fecal fat SC test Diabetes
Patient no. Sex Age (yr) Etiology CP (yr) (g/24 h) (% normal) mellitus
1 M 47 Alcoholic 10 35 0.7
- ■  \ ■■ 1 , M  ■■
2a M 44 Alcoholic 6 42 1.8 —
3 F 55 Idiopathic 7 26 3.8 —
4 M 47 Alcoholic 9 52 0.7 —
5a F 46 Alcoholic 8 26 4.2 —
6a M 48 Alcoholic 11 30 1.2 —
I a M 34 Alcoholic 6 29 3.8 —
8 M 59 Alcoholic 16 34 0.6
9 F 49 Alcoholic 12 40 2,0 —
10 M 43 Alcoholic 8 32 1,2 —
11 M 39 Idiopathic 18 28 1.6 +
12a M 52 Alcoholic 7 78 0.2 —
CPr chronic pancreatitis; SC test, secretin-cerulein test. 
"'Patient participated in both experimental protocols.
All patients had had symptomatic chronic pancreatitis for 
9.8 ±  1.7 years (range, 6 —18 years) and were seen in our 
institution at regular intervals. Diagnosis of chronic pancreati­
tis had been established by a typical clinical history and char­
acteristic abnormalities in abdominal ultrasonography, 
computerized tomography, and endoscopic retrograde cholan­
giopancreatography in all patients. At the time of the study, 
each patient had severe exocrine pancreatic insufficiency estab­
lished by direct pancreatic function test within 12 months of 
the study (secretin-cerulein test: mean trypsin output, 1 .8 % 
±0.4%  of normal mean output) and manifest steatorrhea (fecal 
fat excretion without enzyme supplementation: range, 2 6 - 7 8  
g!day). All patients had been free of acute symptomatic attacks 
of pancreatitis or severe pain for at least 2 years. Pancreatic 
enzyme supplementation and any medication with (potential) 
effects on gastrointestinal motility were discontinued 7 days 
before each study. Chronic pancreatitis was of alcoholic etiol­
ogy in 10 patients, all of whom had discontinued alcohol 
abuse several years ago, and was idiopathic in 2 patients. Two 
patients had diabetes mellitus controlled by insulin for 2 and
4 years, respectively, and were administered 12 and 16 IU, 
respectively, of human insulin with their test meal. No patient 
had evidence of autonomic or somatic neuropathy or other 
major extrapancreatic alcoholic or diabetic complications, and 
there was no history of additional gastrointestinal or other 
relevant disorders. Important clinical features of these patients 
ate presented in Table 1. Five of the patients (patients 2, 5 — 
7, and 12) participated in both experimental protocols.
Gastrointestinal Intubation, Motility 
Recording, and Sampling
Subjects were fasted overnight and then intubated at
6 a m  with a polyvinyl multilumen oroileal tube (largest OD,
7.2 mm) that was placed with its tip in the distal ileum (240 
cm from the mouth). In this position, the aspiration ports (ID, 
2.0 mm) were in the ascending duodenum just proximal to 
the ligament of Treitz, in the midjejunum (90 cm from the 
pylorus), and in the terminal ileum (150 cm from the pylorus)*
Perfusion ports (ID, 1.0 mm) for the dilution marker polyeth­
ylene glycol (45 mg/min) were at the papilla of Vater; for 
intraileai solutions (described below), they were in the distal
ileum (25 cm from the tip of the tube). Seven integrated
i
catheters (ID, 0.8 mm) were perfused with deionized water 
and served as pressure recording ports; three were located in 
the distal antrum (spaced 5 cm apart) and four in the small
intestine (10, 25, 40, and 55 cm distally from the pylorus). 
Correct tube position was reached usually after 3 —5 hours and 
was verified by brief fluoroscopy before the start and after the 
end of each study. After tube placement, continuous duodenal 
polyethylene glycol perfusion and recording of intestinal motil­
ity was begun.
Each perfusion catheter was connected to a low-compliance 
perfusion system13; the voltage output of each calibrated pres­
sure transducer was preamplified and recorded by an eight- 
channel recorder (Sensormedics, Essen, Germany).
From each aspiration site, 2 -3 -m L  aliquots of intraluminal 
contents were aspirated by hand during every 15-minute pe­
riod throughout the study and collected into vials that were 
immersed in ice. To ensure rapid collection of fresh intralumi­
nal samples, the tube to each site was flushed with a volume 
of air equal to its dead space (duodenal, 3 mL; jejunal, 4 mL; 
and ileal, 5 mL) immediately before and after the intestinal 
juice was aspirated. Samples were analyzed on the same day 
or within 2 days of the study. Blood samples were collected 
at 30-minute intervals.
Experimental Design
Protocol 1: correlation of postprandial motility and 
luminal nutrient delivery. Each participant was studied twice 
on separate days and, with a test meal, was administered either 
placebo or pancreatin in random order and double-blind fash­
ion.
Placebo study. Normal subjects (n =  14) and patients 
with pancreatic insufficiency (n =  12) ingested a standard 
homogenized semiliquid test meal within 15 minutes; this 
meal was chosen to minimize intraindividual and interindivid­
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ual variations in gastric emptying. The meal consisted of 41.4 
g of rice starch, 10.2 g of emulsified triolein, and 11.4 g of 
sodium caseinate (i.e., 5 5 %, 30%, and 15%, respectively, of 
total energy content of 1257 kj; total volume, 300 mL; pro­
vided by Dr. Kessler, Fresenius, Oberursel, Germany). It con­
tained phenolsulfonphthalein (PSP; 100 ¡Ig/mL) as a liquid 
delivery marker to luminal sites; absorption of PSP by the 
intact gastric or intestinal mucosa is <  1% per hour.14-18 With 
the meal, all participants were administered the placebo (heat- 
inactivated pancreatin without measurable enzymatic activity).
Pancreatin study. The same participants received an 
identical meal together with pancreatic enzyme supplementa­
tion (pancreatin powder; lipase, 30 kU; amylase, 24 kU; prote­
ases, 2 kU; kindly provided by Dr. Rolle, Sanol GmbH, Mon- 
heim, Germany).
Protocol 2: effect of ileal nutrient perfusion on fed- 
motility pattern. In 8 fasting normal subjects and 5 of the 
patients with chronic pancreatitis participating in protocol 1 
(Table 1), a fed intestinal motility pattern was induced by 
continuous duodenal perfusion (3 mL/min) with a mixture of 
essential amino acids (450 |lmol/min). This perfusate (rather 
than a mixed nutrient emulsion) was chosen because it is an 
established moderate endogenous stimulus of intestinal motil­
ity10 with an energy load (2.4 kj/min) comparable to duodenal 
energy flow rate in the third postprandial hour in the patients 
with untreated pancreatic insufficiency studied in protocol 1 , 
Its intraduodenal perfusion results in negligible delivery of 
unabsorbed energy into the distal intestine. After 1 hour, an 
additional ileal perfusion (3 mL/min) was administered for
30 minutes. Control and test perfusates were administered in 
random order and separated by 4 hours to avoid potential 
carry-over effects.
Test study. The ileal test perfusate consisted of a 
mixed nutrient solution (carbohydrate, 17.5 mg/mL; lipid, 4.5 
mg/mL; and protein, 5.0 mg/mL), with a resulting energy 
perfusion rate of 1.64 kj/min. The energy load and composi- 
tion of ileal nutrient perfusion were chosen to be similar to 
ileal samples in untreated pancreatic insufficiency during the 
third postprandial hour obtained in protocol 1. The proportion 
of ileal nutrients in untreated patients was similar to that of 
die test meal, which is in contrast to normal subjects, in which 
protein, in particular pancreatic enzymes, represents a major 
component of late-postprandial ileal contents.19
Control study. Normal saline instead of nutrients was 
perfused intraileally as the volume control.
Chemical, Motility, and Statistical 
Analyses
In luminal samples, total carbohydrate concentration 
was measured as glucose using a commercial hexokinase-glu- 
cose-6 -phosphate-dehydrogenase assay (Glucoquant; Boeh- 
ringer, Mannheim, Germany) after pretreatment with amylo- 
glucosidase (E.C.3.2.1.3; Sigma Chemical Co., St. Louis, MO) 
as described previously20; the same glucose assay was used to 
measure plasma glucose. Commercial kits were used to deter­
mine luminal lipid (triglycerides plus fatty acids) concentra­
tion enzymatically (Boehringer) and protein concentration 
spectrophotometrically (Bio-Rad protein assay; Bio-Rad Labo­
ratories, Munich, Germany). Luminal energy content was ap­
proximated as the sum of the carbohydrate (at 17.2 kj/g), 
protein (at 17.2 kj/g), and fat (at 38.9 kJVg) contents in each 
sample (1 kj =  0.239 kcal). Luminal pH was determined by 
a pH meter (Metrohm, Herisau, Switzerland),
Concentrations of polyethylene glycol and PSP were mea­
sured and, after correction for the amounts removed proxi- 
mally, were used to calculate intraluminal volume flow rates 
and delivery rates of nutrients and PSP to intestinal sites as 
described previously.19"22 Cumulative duodenal delivery of 
PSP was used to assess gastric liquid meal emptying. The  
intervals from meal intake to cumulative duodenal delivery of  
20%, 50%, and 90% of cumulative PSP delivery to the duode­
nal site were used as a measure of early, middle, and late gastric 
liquid meal emptying times, respectively. The latency between 
duodenal and ileal PSP deliveries (50% of cumulative quantity 
recovered) was used to calculate small intestinal transit time.
Plasma cholecystokinin (CCK) was determined by radioim­
munoassay using antibody T204, which is directed to the 
sulfated tyrosyl region. Its cross-reactivity with sulfated forms 
of gastrin is negligible ( < 2%), and it does not bind to unsul- 
fated gastrins or structurally unrelated peptides. The deteccion 
limit; of the assay is 0.5 pmol/L, and intra-assay and interassay 
precisions are < 8 % and <15%, respectively.23,24
Radioimmunoassay of peptide YY in plasma was performed 
using anti serum code no. 8412-2 (a gift from R. Ekman, D e ­
partment of Neurochemistry, University of Lund, Lund, Swe­
den) raised in rabbits against the N  teixninus of peptide Y Y  
as described previously25 but without conjugation to the carrier 
protein. The antibody cross-reacts 100% with human peptide 
YY. Synthetic human peptide YY (Peninsula Laboratories Eu­
rope Ltd,, Merseyside, St. Helen’s, England) was used for stan­
dards and for preparation of 1251-peptide YY, which was la­
beled according to the stoichiometric chloramine T method 
and purified using high-pressure liquid chromatography.25 D e ­
tection limit of the assay was < 1  pmol/L, and 50% inhibition 
was obtained with 23 pmol/L peptide YY. Recovery of peptide 
YY added to plasma in concentrations between 5 and 50 pmol/ 
L deviated <15%  from expected values. Intra-assay coefficient 
of variation was <5% . The antibody showed no cross-reaction 
with human neuropeptide Y or human pancreatic polypeptide 
at concentrations of up to 500 pmol/L.
Glucagon-like peptide 1 (GLP-1) immunoreactivity was 
measured as described previously.27 Antiserum 390 was raised 
against a synthetic C-terminal decapeptide of amidated GLP- 
1 (proglucagon 9 8 —107) amide coupled to bovine serum albu­
min with carbodiimide.25 The antiserum requires carboxy- 
terminal amidation for binding and cross-reacts fully with  
GLP-1 (72—107) amide but not with C~terminaliy extended 
or deleted forms of GLP-1; it does not cross-react with any 
other members of the glucagon/secretin family of peptides. 
The experimental detection limit in plasma is approximately
1 pmol/L, and the intra-assay coefficient of variation is < 6 %. 
Before radioimmunoassay, plasma samples were extracted with
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Table 2. Cumulative Postprandial Delivery of Nutrient to Smaii Intestinal Sites and Gastric Emptying Times (20%, 50%, and
90% of the meal marker PSP, respectively) and Small Intestinal Transit Time
Normal subjects Pancreatic insufficiency
Placebo Enzymes Placebo Enzymes
Nutrient delivery
Duodenum (kJ) 318 ± 67 328 ± 48 639 +■ 222a 381 ±  1496
Jejunum (kJ) 113 ± 38 126 ± 42 557 ± 198* 308 ±  131"
Ileum {kJ) 69 ± 21 72 ±  29 487 ± 212a 227 ± 105°
Motor responses
Duration of fed pattern (min) 196 ± 22 207 ±  34 131 ± 14 a 170 ± 17b
Gastric emptying (20%) {min) 24.7 ± 3.3 25.2 ±  2.8 36.5 ± 4.1 29.5 ± 3.6
Gastric emptying (50%) {min) 59 ± 6 60 ± 7 66 ± 8 63 ±  a
Gastric emptying (90%) (min) 163 ±  12 159 ±  14 128 ± 10a 148 ±  14°
Small intestinal transit {min) 86 ± 9 85 ± 10 44 it  G& 62 ±  6"
NOTE. Values are expressed as ± SE from normal subjects (n = 14) and patients with pancreatic insufficiency (n = 12) with placebo vs. 
pancreatic enzyme supplementation. 
aP < 0.001 vs. normal subjects. 
bP < 0.01 vs. placebo.
ethanol (final concentration, 70%, vol/vol). The recovery of
GLP-l added to plasma before extraction was 78% ±  8 % 
(mean ±  SD).
Digestive and interdigestive motility patterns were identi­
fied and analyzed by visual inspection as described previously. 
Specifically, phase III motility was defined as uninterrupted 
periods of regular contractions (1 0 -1 2  per minute) for at least
2 minutes, with distal propagation to at least one further 
recording site.10 In addition, antral and duodenal motor activi­
ties were quantified by computer assistance and expressed in 
a motility index defined as ln[AUC +  0.5]. The duration of 
the digestive period was defined as the interval between inges­
tion of the test meal and the termination of the fed motor 
pattern, i.e., occurrence of the next proximal intestinal interdi­
gestive phase III, at the duodenal recording site.28,29
Statistical analyses were performed by using t tests for paired 
(comparisons within subjects: preprandial vs. postprandial, en­
zyme vs. placebo supplementation, and ileal nutrient vs. saline 
perfusion) or unpaired (comparisons between normal subjects 
and patients) data, respectively. Responses to ileal nutrient vs. 
saline perfusions were compared by using the nonparametric 
Wilcoxon signed-rank test for paired data.30 Data are expressed 
as means ±  SE, unless indicated otherwise.
Results
Protocol 1: Postprandial Motility and 
Luminal Nutrient Delivery
Motility patterns. In normal subjects, the fed 
motor pattern persisted for 196 ±  22 minutes after the 
start of the meal with placebo (Table 2 and Figure 1) 
and was then followed by a phase III of the interdigestive 
motor complex originating in the duodenum or proximal 
jejunum; in no case did it originate in the antrum. A 
similar duration of fed motility was observed with pan- 
creatin supplementation (Table 2).
Patients with pancreatic insufficiency maintained a fed 
motility pattern for 131 ±  14 minutes after the placebo 
meal, which was significantly shorter compared with nor­
mal subjects (P <  0.001; Table 2 and Figure 2). In the 
same patients, pancreatin supplementation with the meal 
was associated with a longer duration of fed pattern com-
pared with placebo (170 17 minutes; P 0 . 016;
Table 2 and Figure 3). At the termination of the fed 
period, mean nutrient flow rate was 984 ± 5 1 8  J/min 
in the duodenum and 1062 ±  498 J/m in in the ileum
(Figure 3).
In contrast to the duration of fed pattern, motility 
indices within the postprandial period were similar in 
normal subjects and patients (6.23 ±  0.13 and 6.10 ±  
0,37, respectively) and were not influenced by addition 
of enzymes to the meal (6.30 ± 0 . 1 4  and 6.21 ±  0.11, 
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Figure 1. Duration of fed motor pattern and delivery of nutrient to 
duodenum (• )  and ileum (O) in 14 normal subjects after ingestion 
of a test meal (1257 kJ) at 0 hours.
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Postprandial Minutes
Figure 2. Duration of fed motor pattern and delivery of nutrient to 
duodenum (• )  and ileum (O) in 12 patients with untreated pancreatic 
insufficiency after ingestion of a test meal (1257 kJ) at 0 hours.
gestive phase III did not differ between normal subjects 
and patients (duration, 6.9 — 1.2 vs. 7.5 it  2.1 minutes; 
propagation velocity, 4.5 ±  0.6 vs. 4*1 ±  0.7 cm/min, 
respectively). Again, there was no effect of pancreatin 
supplementation.
Cumulative luminal nutrient and marker deliv­
ery. In normal subjects, nutrient delivery to intestinal 
sites was not affected by addition of pancreatic enzymes 
to the test meal; under both conditions, cumulative en­
ergy loads to the duodenum, jejunum, and terminal il­
eum were about 25%, 10%, and 6% of the energy con­
tent of the meal ingested, respectively (Table 2 and 
Figure 1).
In patients with pancreatic insufficiency without en­
zyme supplementation (i.e., placebo), nutrient delivery 
to all intestinal sites was significantly increased compared 
with healthy subjects (P <  0.001; Table 2 and Figure
2); cumulative duodenal, jejunal and ileal energy loads 
were about 51%, 44%, and 39% of total, respectively.
When pancreatic enzymes were administered together 
with the meal, duodenal, jejunal, and ileal nutrient deliv­
eries in patients were decreased to 30%, 27%, and 18% 
of total, respectively (P <  0.001 vs. placebo; Table 2 
and Figure 3).
Cumulative gastric emptying of 20% of the marker 
tended to occur later in untreated patients compared 
with healthy subjects (P =  0.06), but emptying of 50% 
occurred at similar rates in both normal subjects and 
patients (Table 2). By contrast, late (90%) gastric empty­
ing rates were consistently and markedly increased in 
patients compared with controls (P <  0.001). Thus, the 
interval between meal ingestion and emptying of 90% 
of the meal was shortened by nearly 30% compared with 
normals (Table 2). Similarly, small intestinal transit oc­
curred faster in pancreatic insufficiency without enzyme
supplementation; transit velocity was nearly doubled 
compared with healthy controls (P <  0.001; Table 2).
Enzyme supplementation had no effect in normal sub­
jects. By contrast, in pancreatic insufficiency, enzyme 
supplementation decelerated both late gastric emptying 
and small intestinal transit (both P <  0.01 vs. placebo), 
although rates did not reach values observed in normal 
subjects (Table 2).
In both normal subjects and patients, cumulative re­
coveries of the meal marker PSP were similar under all 
experimental conditions and were between 78% and 97% 
of the amount administered. There was a consistent tight 
correlation between duodenal deliveries of PSP and en­
ergy (in each experiment, r >  0.9 and P <  0.001).
Luminal nutrient flow at end of digestive period.
At the time of the termination of the fed period, i.e., at 
the occurrence of the first interdigestive motor pattern, 
normal subjects had mean luminal nutrient flow rates of
486 ±  62 J/min in the duodenum and 265 ±  72 J/min 
in the ileum (Figure 1). Ileal energy was composed of 39% 
carbohydrate, 46% protein, and 15% lipids.
By contrast, in patients with placebo-treated pancreatic 
insufficiency, mean nutrient flow rates at the end of the fed 
period were nearly four times greater in the duodenum 
(1796 ±  417 J/min) compared with normal subjects (P <  
0.001), and ileal nutrient exposure was increased 10-fold
(2575 ±  1014 J/min; P <  0.001 vs. normals; Figure 2),
In untreated patients, ileal energy was composed of 52% 
carbohydrate, 14% protein, and 34% lipids.
Plasma glucose and hormone responses. Plasma
glucose increased from preprandial values of 93 — 3 to 126 
±  4 mg/dL at 60 minutes after the meal in normal subjects; 
there was no effect of enzyme supplementation (not shown). 
In patients with chronic pancreatitis, plasma glucose in­
creased after the placebo meal from 99 — 6 to 132 ±  8
Postprandial Minutes
Figure 3. Duration of fed motor pattern and delivery of nutrient to 
duodenum ( • )  and ileum (O) in 12 patients with pancreatic insuffi­
ciency after ingestion of a test meal (1257 kJ) together with pancreatic 
enzyme supplementation at 0 hours.
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Table 3. Plasma CCK, Peptide YY, and GLP-1: Preprandial and Postprandial Peak Concentrations and integrated Incremental
Responses in Healthy Subjects and Patients With Pancreatic Insufficiency Without and With Pancreatic Enzyme 
Supplementation
Normal subjects (n = 14) Pancreatic insufficiency (n = 12)
Placebo Enzymes Placebo Enzymes
CCK
•
Preprandial 2.0 ±  0.4 1.9 ±  0.4 2.3 ± 0.5 2.2 ±  0.5
Postprandial peak (pmol/L) 5.7 ±  0.8 6.1 ±  1.1 4.3 ± 0.8 5.3 ±  1,1
Integrated incremental response over preprandial
{Æpmol/L • 180 min) 453 ±  67 471 ±  75 249 ± 36a 420 ±  58b
Peptide Y Y
Preprandial 1.5 ±  0.3 2.1 ±  0.4 3.6 ± 0.5 3.1 ±  0.5
Postprandial peak (pmol/L) 4.6 ±  1.5 5.9 ±  2.7 8.5 ± 1.7 6.8 ±  1.4
integrated incremental response over preprandial
(.Æpmol/L • 180 min) 351 ±  87 447 ±  135 1048 ± 184a 665 ±  252
GLP-1
Preprandial 8.5 ±  1.1 9.6 ±  1.2 10.4 ± 2.2 12.0 ±  1.9
Postprandial peak (pmol/L) 25.0 ±  4.3 21.5 ±  4.1 52.0 ± 11.3a 32.0 ±  5.5Ö
integrated incremental response over preprandial
(.Æpmoi/L • 180 min) 1545 ±  501 1424 ±  489 4584 ± 1050a 2970 ± 546*
NOTE. For each peptide there was a significant (P < 0.01) increase over baseline in response to the meal with both placebo and enzymes in 
normals and patients, Values are expressed as means ± SE. 
aP <  0.01 vs. normal subjects. 
bP < 0.01 vs. placebo.
mg/dL and after the meal with pancreatin from 97 ±  7 to tal responses to the placebo meal were significantly
136 ±  9 mg/dL. greater than in healthy subjects (P <  0.001); this exces- 
Preprandial CCK plasma concentrations were similar sive increase was partially reverted by enzyme supple- 
before both meals in all participants and did not differ mentation (Table 3).
between normal subjects and patients (Table 3). Post- 
prandially, plasma CCK increased about threefold in 
healthy individuals after both placebo and pancreatin 
meals (P <  0.01). In patients, the prandial peak increase
Protocol 2: Effect of Ileal Nutrient 
Perfusion on Fed Motility
Duodenal perfusion with essential amino acids in-
in plasma CCK was about twofold after the placebo meal, duced a persistent fed motility pattern at all small intesti-
and the integrated CCK response was significantly nal sites in each subject. Intestinal motor activities were
smaller than in healthy subjects (P <  0.002). By contrast, similar before either ileal perfusion both in healthy indi-
pancreatin supplementation was associated with a sig- viduals and in patients with pancreatic insufficiency.
nificantly greater prandial CCK response compared with 
placebo (P <  0.01; Table 3)-
Pattern and activity index of digestive motility were 
not altered by ileal saline perfusion in either normals or
In all subjects plasma peptide YY increased postpran- patients (Figures 4A and 5A). By contrast, ileal nutrient
dially (P <  0.01). There was an insignificant trend to- perfusion induced marked intestinal motility changes in
wards greater plasma peptide YY concentrations in pa- both groups. In the presence of continuing endogenous
tients compared with healthy subjects both before the stimulation, seven of eight ileal nutrient perfusions (in
meal and for postprandial peak values (Table 3); on the contrast to zero of eight ileal saline perfusions; P <  0.01)
other hand, the integrated incremental response to the in normal subjects and four of five nutrient perfusions
placebo meal was significantly greater in untreated pa- (vs. zero of five saline perfusions; P <  0.05) in patients 
tients (P <  0.001) but not in treated patients compared were followed by a phase III—like motor activity front
with healthy subjects (Table 3). originating in the duodenum or proximal jejunum after
Before the meals, GLP-1 plasma levels were similar a mean of 17.8 ±  6.7 minutes in normals and 21.6 ±
in normal subjects and patients (Table 3). GLP-1 concen- 7.2 minutes in patients (Figures 4B and 5B)\ there was
trations increased in response to the meal in all subjects no antral involvement. These activity fronts were propa-
(P <  0.01). There was no difference between responses gated distally with a mean migration velocity of 3*9 ±
between placebo and enzyme meals in normals. In pa- 0.6 or 4,2 ±  0.8 cm/min, respectively, and were always
tients, postprandial peak values and integrated incremen- followed by a period of motor quiescence (phase I —like
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0 are unknown (besides late-postprandial disappearance o f
stimulatory nutrients from the proximal intestinal lu­
men). However, there is evidence that regulatory mecha­
nisms may be recruited late postprandially by the distal 
intestine that may facilitate or induce the conversion 
from the digestive to the interdigestive state, In several 
species including humans, increased ileal nutrient expo­
sure decreases stimulated motor and secretory functions 
into the basal range.9-12,20,31“38
As an implication, clinical malabsorption syndromes, 
such as end-stage chronic pancreatitis, may be associated 
with abnormal motility responses. However, only a few 
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Figure 4. Effects of ileal perfusion with (4) NaCl and (8) nutrient on 
intestinal motility in a single healthy subject. A fed motor pattern 
induced by continuous duodenal perfusion with essential amino acids 
(EAA) was maintained in response to ileal NaCl but was disrupted by 
ileal nutrient. The fed pattern was replaced by a migrating motor 
activity front followed by motor quiescence.
activity) for another 13.1 ±  2,1 minutes or 10.6 ±
3.2 minutes, respectively. Decreased motor activity was 
always observed in response to ileal nutrient, including 
in the two individuals in whom no phase III—like activity 
occurred.
Discussion
The major findings of this study can be summa­
rized as follows. First, the gastrointestinal motor response 
to a liquid low-energy meal differed in patients with 
severe pancreatic exocrine insufficiency compared with 
normal subjects. Transit of chyme (gastric emptying and 
small intestinal transit) was accelerated, and the duration 
of fed pattern was shortened, resulting in earlier transi­
tion to the subsequent interdigestive pattern. Second, 
these motor changes were reversed by enzyme supple­
mentation with the test meal, i.e., decreased malabsorp­
tion, siiggesting that the altered motor response was asso­
ciated with or caused by increased nutrient delivery to 
the distal intestine. Third, analogous motility changes 
were reproduced by perfusing nutrients into the ileal 
lumen; despite continuous endogenuous stimulation, fed 
motor activity responded by conversion into an interdi­
gestive-like pattern both in healthy subjects and in pa­
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Figure 5. Effects of ileal perfusion with (A) NaCl and (5) nutrient on 
intestinal motility in a patient with pancreatic insufficiency. The fed 
pattern induced by intraduodenal amino acid (EAA) perfusion remained 
unchanged during ileal NaCl perfusion; by contrast, ileal nutrients 
induced phase 111-*like motor activity and subsequent motor quies­
cence.
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digestive antral motility was reported to be enhanced in 
patients with chronic pancreatitis,6 but normal duodenal
As stimulus, we used continuous intraduodenal essential 
amino acid perfusion at an established rate that was 
activity was observed in another study.3'* In pancreatecto- known to induce fed motor and secretory responses10 and 
mized dogs, interdigestive antral but not duodenal motor with an energy load similar to that present in the duode- 
activity was increased compared with normal controls.40 nal lumen in the third postprandial hour. Although theo- 
Similarly, it is unclear if postprandial motility is al- reticaily it might have been preferable to use mixed nu- 
tered. Gastric emptying has been reported to be acceler­
ated in patients with pancreatic insufficiency,5 but this
was not confirmed in a subsequent investigation when mental conditions.
trients as the stimulus, such a perfusate may be partly 
delivered to the distal lumen, thus confounding experi-
emptying rates were corrected for gastric volume output.7 Because under the specific experimental conditions of
In a less homogenous patient population with varying this study ileal nutrients disrupted the fed pattern and
degrees of insufficiency, increased gastric emptying rates induced an interdigestive-like motor pattern in the ma-
late postprandially and decreased proximal intestinal jority of both normals and patients, we conclude that, in
transit rates were reported; however, distal intestinal nu- the presence of weak endogenous duodenal stimulation,
trient deliveries, manometric responses, and effects of increased ileal nutrient exposure may induce or facilitate
enzyme supplementation were not studied.4 In another conversion from the digestive into the interdigestive
study, postprandial antral motility was unchanged, but state. This suggests that in pancreatic insufficiency, in-
gastric emptying and intestinal nutrient deliveries were 
not determined.6 The original notion of accelerated gas-
creased delivery of malabsorbed nutrient to the distal 
intestine contributed to the earlier transition from the
trie emptying in pancreatic insufficiency in the absence digestive into the subsequent interdigestive period.
On the other hand, in normal subjects, luminal, espe­
cially intraileal, nutrients delay (rather than accelerate) 
gastric emptying20,33,42 and small intestinal transit (“ileal
4  I  4  2
brake” ’ ), Therefore, the observation of accelerated gas-
of active inflammation was strengthened recently by 
findings in an experimental dog model.41
We now report markedly altered gastrointestinal mo­
tility responses to a liquid low-energy meal in patients 
with severe pancreatic insufficiency. Gastric emptying trie emptying and small intestinal transit in untreated 
and small intestinal transit were more rapid, and the pancreatic insufficiency and increased postprandial nutri- 
duration of the fed motor pattern was significantly short- ent concentrations throughout the small intestinal lumen 
ened compared with healthy subjects. Decreased transit suggests that additional regulatory mechanisms may be 
time through the proximal gastrointestinal tract, i.e., altered.
shorter nutrient exposure of the stimulatory segments of It might be argued that disturbed motor regulation
the gut, contributed to the shorter length of the digestive in patients may have been caused by alcoholic or diabetic
period. autonomic neural alterations. However, there was no evi-
On the other hand, at the time of (premature) termina- dence for autonomic dysfunction in any of the patients, 
tion of the fed pattern in untreated patients, gastric emp- and motor responses did not differ among diabetic and 
tying was incomplete and duodenal nutrient exposure nondiabetic patients, or among alcoholic and idiopathic 
was fourfold greater than required to maintain fed motil- chronic pancreatitis. Prandial blood glucose levels may 
ity in normal subjects. These observations suggest either also have influenced gastric emptying43”45 but were simi- 
that the overall generation of or responsiveness to luminal lar in normal subjects and patients throughout the study, 
stimuli may be decreased in these patients and/or that An underlying motor disturbance is unlikely because 
additional inhibitory mechanisms were activated by in- manometric motility patterns were normal in both the 
creased nutrient delivery into the distal small bowel, digestive and interdigestive periods, which is similar to 
which counterbalanced the stimulatory effects of duode- what has been reported by others.6,46 Finally, because 
nal nutrient exposure and induced premature conversion enzyme supplementation partially reverted motility 
from the fed to the interdigestive motility state. The changes in patients, it is likely that the responsible mech- 
latter explanation was supported by the observation that anism involves malabsorbed nutrients rather than a pre­
enzyme supplementation that decreased malabsorption existing motor disturbance.
also reverted motility changes. Whether motor changes in response to decreased di-
To test the hypothesis that ileal nutrient exposure gestion and/or increased distal intestinal nutrient deliv- 
participates in the regulation of the fed-interdigestive ery are mediated by diminished release of regulatory pep-
transition, we perfused nutrient intraileally in normal 
subjects and patients with pancreatic insufficiency and
tides remains uncertain. Lack of endogenous pancreatic 
polypeptide release caused by pancreatic insufficiency6,46
determined effects on endogenously stimulated motility. may contribute to motility changes. Indeed, in dogs,
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exogenous pancreatic polypeptide prolonged the fed-mo- meals.57 59 Furthermore, it remains speculative if in pa-
tor pattern. 7 However, this hypothesis would not explain tients with pancreatic insufficiency motility changes oc-
why enzyme treatment reverted motor changes in our cur after meals of different composition and if they have
study. additional pathophysiological implications: nutrient ab-
Another candidate mechanism is decreased postpran- sorption may be further compromised because of acceler-
dial release of CCK, which is believed to participate ated transit and decreased mucosal chyme exposure.
in inducing and maintaining the fed state and to be a 
physiological inhibitor of gastric emptying.48 We ob­
served that, in our patients with severe untreated pancre- to enzyme therapy, 
atic insufficiency, CCK release in response to the liquid 
test meal was decreased but was restored by enzyme 
supplementation. These findings are explained by slower 
luminal generation of stimulatory digestion products and 
confirm earlier studies using different test meals.49-51 
Thus, a diminished postprandial CCK response in pan­
creatic insufficiency accelerates gastric emptying. How­
ever, an exclusive role of decreased CCK release is un­
likely for the following two reasons. First, even complete 
CCK-receptor blockade by a selective CCK-receptor an­
tagonist causes only moderate (about 40%) acceleration 
of human gastric emptying of a liquid mixed meal very 
similar to the one used by us.48 It is unlikely that the 
comparatively small difference in CCK release observed 
in our study could have been the sole mechanism respon­
sible for the pronounced motor effects. Second, differ­
ences in CCK responses occurred within the first 2 post­
prandial hours when gastric emptying rates did not 
differ. Therefore, although decreased CCK release may 
contribute to the observed differences, it is unlikely that 
it is the only mechanism.
Late-postprandial motor events may also be regulated 
by hormones released from the distal gut, such as peptide
p  a
YY or GLP-1, in response to increased nutrient deliv­
ery. We found both peptide YY and GLP-1 to be in­
creased in pancreatic insufficiency after the placebo meal 
compared with controls, which is similar to previous 
reports.53'54 Excessive release of both peptides was par- 
tially reversed by enzyme supplementation, suggesting 
that increased delivery of nutrients to the distal intestine 
was responsible. However, whether peptide YY or GLP-1 
participate as regulators is uncertain because both retard 
rather than accelerate gastrointestinal transit.55,56
For methodological reasons, a liquid meal was used 
instead of a (more physiological) solid-liquid meal, and 
our conclusions need to be limited to these experimental 
conditions. In particular, we did not address the issue 
whether the transition from postprandial to interdiges­
tive motility may also be regulated by ileal nutrients 
under normal conditions. In our healthy individuals, the 
meal was absorbed rapidly and nearly completely, and 
the resulting physiological malabsorption was far lower 
compared with what is known from more regular
Moreover, such motor disturbances may explain why in 
some patients postprandial abdominal symptoms respond
References
1. DiMagno EP, Hendricks JC, Go VLW, Dozois RR. Relationships 
among canine fasting pancreatic and biliaty secretions, pancre­
atic duct pressure, and duodenal phase III motor activity— Bold- 
yreff revisited. Dig Dis Sci 1979;24:689-693.
2. Layer P, Chan ATH, Go VLW, DiMagno EP. Human pancreatic 
secretion during phase II antral motility of the interdigestive cycle, 
1988. Am J Physiol 1988;254:G249-G253,
3. Vantrappen G, Peeters TL, Janssens J. The secretory component 
of the interdigestive migrating motor complex in man. Scand J 
Gastroenterol 1979;14:663-667.
4. Johansson C, Schmidt DN, Hellstrom PM. Changed integrated 
gastrointestinal response to a mixed meal in exocrine pancreatic 
insufficiency. Pancreas 1992;7:205-211.
5. Long WB, Weiss JB. Rapid gastric emptying of fatty meals in 
pancreatic Insufficiency. Gastroenterology 1974;67:920-925.
6. Pleramico 0, Dominguez-Munoz JE, Nelson DKf BGck Wr Buchler 
M, Malfertheiner P. Interdigestive cycling in chronic pancreatitis: 
altered coordination among pancreatic secretion, motility and 
hormone release. Gastroenterology 1995;109:224-230.
7. Regan PT, Malagelada JR, DiMagno EP, Go VLW. Postprandial 
gastric function in pancreatic insufficiency. Gut 1979; 20:249- 
254.
8. Guarner L, Rodriguez R, Guarner F, Malagelada J-R. Fate of oral 
enzymes in pancreatic insufficiency. Gut 1993;34:708-712.
9. Jain NK, Boivin M, Zinsmeister AR, Brown ML, Malagelada JR, 
DiMagno EP. Effect of perfusing carbohydrates and amylase In­
hibitor into the iieum on gastrointestinal hormones and gastric 
emptying of homogenized meal. Gastroenterology 1989;96: 
377-387,
10. Layer P, Peschel S, SchlesingerT, Goebell H. Human pancreatic 
secretion and intestinal motility: effects of ileal nutrient perfu­
sion. Am J Physiol 1990;258:G196-G201.
11. Read NW, McFarlane A, Kinsman RJ, Bates TE, Biackhail NW, 
Farrar GBJ, Hall JC, Moss G, Morris AP, O'Neill B, Welch I, Lee 
Y, Bloom SR. Effect of infusion of nutrient solutions into the ileum 
on gastrointestinal transit and plasma levels of neurotensin and 
enteroglucagon. Gastroenterology 1984;86:274-280.
12. Spiller RC, Trotman IF, Higgins BE, Ghatei MA, Grimble GK, Lee 
YC, Bloom SR, Misiewicz JJ, Silk DBA. The ileal brake-inhibition 
of jejunal motility after Ileal fat perfusion in man. Gut 1984; 25: 
365-374.
13. ArndorferRC, Stef JJ, Dodds WJ, LinehanJH, Hogan WJ. Improved 
infusion system for intraluminal esophageal manometry. Gastro­
enterology 1977;73:23-27.
14. Schedl HP, Miller D, White D. Use of polyethylene glycol and 
phenol red as unabsorbed indicators for intestinal absorption 
studies in man. Gut 1966;7:159-161.
15. Bloom DS, Jacobson ED, Grossman Ml. Validation of dilution 
indicators In the stomach. Gastroenterology 1967;52:205-210.
16. Ivey KJ, Schedl HP. Gastric nonabsorbable Indicators for studies 
in man. Gastroenterology 1970;59:234-239.
17. Allch AA, Tan R, Wittmers LE Jr. Phenol red as volume marker in
May 1997 MOTILITY IN CHRONIC PANCREATITIS 1633
rat stomach with mucosal damage. J Pharmacol Meth 1984; 11: 
299-304.
18. Nakamura J, Takada S, Ohtsuka N, Heya T, Ueda S, Hamaura T, 
Yamamoto A, Kimura T, Sezaki H. An assessment of gastric 
ulcers in vivo: enhancement of urinary recovery after oral adminis­
tration of phenoisulfonphthalein in rats. J Pharm Dyn 1984; 7: 
485-491.
19. Layer P, Go VLW, DiMagno EP. Fate of pancreatic enzyme during 
aboral smali intestinal transit in humans. Am J Physiol 1986; 
251:G475-G480.
20. Layer P, Zlnsmeister AR, DiMagno EP. Effects of decreasing intra- 
luminal amylase activity on starch digestion and postprandial 
gastrointestinal function in humans. Gastroenterology 1986; 91: 
41-48.
21. Go VLW, Hofmann AF, Summerskill WHJ. Simultaneous measure­
ments of total pancreatic, biliary and gastric outputs in man using 
a perfusion technique. Gastroenterology 1970;58:321-328.
22. Layer P, Jansen JBMJ, Chertan L, Lamers CBHW, Goebell H. 
Feedback regulation of human pancreatic secretion: Effects of 
protease inhibition on duodenal delivery and small intestinal tran­
sit of pancreatic enzymes. Gastroenterology 1990; 98:1311- 
1319.
23. Jansen JBMJ, Lamers CBHW. Radioimmunoassay of cholecysto- 
kinin: production and evaluation of antibodies. J Clin Chem Bio- 
chem 1983;21:387-394.
24. Jansen JBMJ, Lamers CBHW. Radioimmunoassay of cholecysto- 
kinin in human tissue and plasma. Clin Chim Acta 1983; 131: 
305-316.
25. Holst JJ, Bersani M. Assays for peptide products of somatostatin 
gene expression. In: Conn MP, ed. Methods in neurosciences. 
Volume 5, San Diego: Academic 1991:3-22.
26. Ekman Rr Wahlestedt C, Böttcher G, Sundler F, Hakanson R, 
Panula P. Peptide YY-like immunoreactivity in the central nervous 
system of the rat. Regul Pept 1986;16:157-168.
27. 0rskov C, Jeppesen J, Madsbad S, Holst JJ. Proglucagon prod­
ucts In plasma of noninsulin-dependent diabetics and nondia- 
betlc controls in the fasting state and after oral glucose and 
intravenous arginine. J Clin Invest 1991;87:415-423.
28. Code CF, Marlett JA. The interdigestive myo-electric complex of 
the stomach and small bowel of dogs. J Physiol 1975; 246:298- 
309.
29. Kellow JE, Borody TJ, Phillips SF, Tucker RL, Haddad AC. Human 
interdigestive motility: variations in patterns from esophagus to 
colon. Gastroenterology 1986;91:386-395.
30. Box GEP, Hunter WS, Hunter JS. Statistics for experimenters. 
New York: Wiley, 1978.
31. Fone RD, Horowitz M, Read NW, Dent J, Maddox A. The effect 
of terminal ileal triglyceride infusion on gastroduodenal motility 
and the intragastric distribution of a solid meal. Gastroenterology 
1990;98:568-575.
32. Harper AA, Hood AJC, Mushens J, Smy JR. Inhibition of external 
pancreatic secretion by intracolonic and intraileal infusions in 
the cat. J Physiol (Lond) 1979;292:445-454.
33. Holgate AM, Read NW. Effect of ileal infusion of intralipid on 
gastrointestinal transit, ileal flow rate, and carbohydrate absorp­
tion in humans after ingestion of a liquid meal. Gastroenterology 
1985;88:1005-1011.
34. Jain NK, Boivin M, Zinsmeister AR, DiMagno EP. The ileum and 
carbohydrate mediated feedback regulation of postprandial pan­
creaticobiliary secretion in normal humans. Pancreas 1991; 6: 
495-505.
35. Laugier R, Sarles H. Action of oleic acid on the exocrine pancre­
atic secretion of the conscious rat: evidence for an anti*cholecys- 
toklnin-pancreozymin factor. J Physiol 1977;271:81-92.
36. Layer P, Schlesinger T, Goebell H. Modulation of periodic interdi­
gestive gastrointestinal motor and pancreatic function by the 
ileum. Pancreas 1993;8:426-432.
37. Siegle M-L, Schmid H-R, Ehrlein H-J. Effects of ileal infusions of 
nutrients on motor patterns of canine small intestine. Am J Phys­
iol 1990;259:G78-G85.
38. Spiller RC, Trotman IF, Adrian TE, Bloom SR, Misiewicz JJ, Silk 
DBA. Further characterisation of the ' ‘ileal brake” reflex in man— 
effect of ileal infusion of partial digests of fat, protein, and starch 
on jejunal motility and release of neurotensin, enteroglucagon, 
and peptide YY. Gut 1988;29:1042-1051.
39. Brugge WR, Burke CA, Brand DL, Chey WY. Increased interdiges­
tive pancreatic trypsin secretion in alcoholic pancreatic disease. 
Dig Dis Sci 1985;30:431-439.
40. Malfertheiner P, Sarr MG, DiMagno EP. Role of the pancreas in 
the control of interdigestive gastrointestinal motility. Gastroenter­
ology 1989;96:200-205.
41. Mizumoto A, Sarr MG, DiMagno EP. Which pancreatic enzymes 
normalize rapid gastric emptying in canine chronic pancreatic 
insufficiency (abstr)? Int J Pancreatol 1994; 16:326.
42. Miller U, Malagelada J-R, Taylor WF, Go VLW. 1981. Intestinal 
control of human postprandial gastric function: the role of compo­
nents of jejunoileal chyme in regulating gastric secretion and 
gastric emptying. Gastroenterology 1981;80:763-769.
43. Aylett P. Gastric emptying and change of blood glucose level, 
as affected by glucagon and insulin. Clin Sci 1962;22:171- 
178.
44. Barnett JL, OwyangC. Serum glucose as a modulator of Interdi- 
gestive gastric motility. Gastroenterology 1988;94:739-744.
45. McGregor IL, Gueller R, Watts HD, Meyer JH. The effect of acute 
hyperglycemia on gastric emptying in man. Gastroenterology 
1976;70:190-196.
46. Glaser B, Vinik Al, Sive AA, Floyd JC. Plasma human pancreatic 
polypeptide responses to administered secretin: effects of surgi­
cal vagotomy, cholinergic blockade, and chronic pancreatitis. J 
Clin Endocrinol Metab 1980;50:1094-1099.
47. Thor PJ, Konturek JW, Konturek SJ, Pancreatic polypeptide 
and intestinal motility in dogs. Dig Dis Sci 1987 ;32 :513- 
519.
48. Fried M, ErlacherU, SchwizerW, LochnerC, KoerferJ, Beglinger 
C, Jansen JB, Lamers CB, Harder F, Bischof-Delaloye A, Stalder 
GA, Rovati L. Role of cholecystokinin in the regulation of gastric 
emptying and pancreatic enzyme secretion in humans: studies 
with the cholecystokinin-receptor antagonist loxiglumide. Gastro­
enterology 1991;101:503-511.
49. Jansen JBMJ, Jebbink MCW, Mulders HJA, Lamers CBHW. Effect 
of pancreatic enzyme supplementation on postprandial plasma 
cholecystokinin secretion in patients with pancreatic insuffi­
ciency. Regul Pept 1989;25:333-342.
50. Nustede R, Kohler H, Folsch UR, Schafmayer A. Plasma concen­
trations of neurotensin and CCK in patients with chronic pancre­
atitis with and without enzyme substitution. Pancreas 1991; 6: 
260-265.
51. Glasbrenner B, Dominguez-Monz JE, Nelson DK, Riepl RL, 
Buchler M, Malfertheiner P. Relationship between postprandial 
release of CCK and PP in health and in chronic pancreatitis. 
Regul Pept 1994;50:45-52.
52. Layer P, Holst JJ, Grandt D, Goebell H. Ileal release of gluca- 
gon-like-1 peptide (GLP-1): association with inhibition of gas­
tric acid secretion In humans. Dig Dis Sci 1995;40:1074- 
1082.
53. Adrian TE, Savage AP, Bacarese-Hamilton AJ, Wolfe K, Besterman 
HS, Bloom SR. Peptide YY abnormalities in gastrointestinal dis­
eases. Gastroenterology 1986;90:379-384.
54. Layer P, Holst JJ, v. d. Ohe M, Goebell H. Mechanisms of 
postprandial glucagonlike peptide-1 (GLP-1) release: role of 
intestinal nutrient delivery (abstr). Int J Pancreatol 1994; 16: 
326.
55. Savage AP, Adrian TE, Carolan G, Chatterjee VK, Bloom SR. Ef­
fects of peptide YY (PYY) on mouth to caecum intestinal transit
1634 LAYER ET AL GASTROENTEROLOGY Vol. 112, No. 5
time and on the rate of gastric emptying in healthy volunteers. 
Gut 1987;28:166-170.
56. Wettergren A, Schjoldager B, Mortensen PE, Myhre J, Christian­
sen J, Holst JJ. Truncated glucagon-like peptide-1 (proglucagon 
78-107 amide) inhibits gastric and pancreatic functions in man. 
Dig Dis Sci 1993;38:665-673.
57. Anderson IH, Levine AS, Levitt MD. incomplete absorption of the 
carbohydrate In all-purpose wheat flour. N Engl J Med 1981; 304: 
891-892.
58. Levitt MD, Hirsh P, FetzerCA, Sheahan M, Levine AS. H2 Excretion 
after ingestion of complex carbohydrates. Gastroenterology 
1987;92:383-389.
59. Stephen AM, Haddad AC, Phillips SF. Passage of carbohydrate 
into the colon. Gastroenterology 1983;85:589-595.
Received April 10, 1995. Accepted January 6, 1997.
Address requests for reprints to: Peter Layer, M.D., Department 
of Medicine, Israelitic Hospital, Orchideenstieg 14, 22297 Hamburg, 
Germany. Fax: (49) 40-51125-227.
Supported by grants La 483/2-6 and La 483/5-3 from Deutsche 
Forschungsgemeinschaft and by the Danish Medical Research Coun­
cil and Schwarz GmbH Monheim, Germany.
The authors thank L. Cherian and C. Bertram for skillful technical 
assistance and M. Wissmann and A. Ulrich for expert secretarial 
assistance.
